The design of co-crystals requires knowledge of robust supramol. synthons. The sulfoxide is a potent H bond acceptor and was used as a co-crystal former with a range of NH functional groups, via N-H···O=S H bonds. The NH functional group retains favorable H bond motifs from its own structure in all cases where this is possible, with the sulfoxide interacting in a discrete, capping fashion in four cases and in a bifurcated, bridging fashion in the three other cases presented here. Crystallog. data are given for 7 co-formers, dibenzyl sulfoxide and cyclohexanecarbothioamide
Doctor of PhilosophyDepartment of ChemistryChrister B. AakeroyThe impact of the molecular electrosta...
The research presented herein focus upon crystal engineering of co-crystals with an emphasis upon th...
Doctor of PhilosophyDepartment of ChemistryChrister B. AakeröyFour different methods; molecular elec...
A systematic crystal engineering study was undertaken to investigate how different electronic substi...
This thesis focuses on design principles in crystal engineering, from the development of our knowled...
This thesis is focused on the design and synthesis of a diverse range of novel organosulfur compound...
Sulfadimethoxine (SDM) cocrystal formation was screened using coformers with cyclic amines, amide, c...
Four new crystal structures of pharmaceutical molecule furosemide with GRAS coformers are reported a...
A novel 1:1 cocrystal between p-toluenesulfonamide and triphenylphosphine oxide has been prepared an...
The sulfamethizole antibiotic drug has rich hydrogen bond functionalities (donors: amine NH<sub>2</s...
YesThe creation of co-crystals as a route to creating new pharmaceutical phases with modified or def...
Co-crystallization alters the molecular interactions and composition of pharmaceutical materials, an...
In the context of pharmaceutical development, it is abundantly clear that there is a need for greate...
peer-reviewedThe influence of temperature and solvent on the solid-liquid phase diagram of the 1:1 s...
Co-Crystals are crystalline materials formed by bonding between a drug and co-former. This alternati...
Doctor of PhilosophyDepartment of ChemistryChrister B. AakeroyThe impact of the molecular electrosta...
The research presented herein focus upon crystal engineering of co-crystals with an emphasis upon th...
Doctor of PhilosophyDepartment of ChemistryChrister B. AakeröyFour different methods; molecular elec...
A systematic crystal engineering study was undertaken to investigate how different electronic substi...
This thesis focuses on design principles in crystal engineering, from the development of our knowled...
This thesis is focused on the design and synthesis of a diverse range of novel organosulfur compound...
Sulfadimethoxine (SDM) cocrystal formation was screened using coformers with cyclic amines, amide, c...
Four new crystal structures of pharmaceutical molecule furosemide with GRAS coformers are reported a...
A novel 1:1 cocrystal between p-toluenesulfonamide and triphenylphosphine oxide has been prepared an...
The sulfamethizole antibiotic drug has rich hydrogen bond functionalities (donors: amine NH<sub>2</s...
YesThe creation of co-crystals as a route to creating new pharmaceutical phases with modified or def...
Co-crystallization alters the molecular interactions and composition of pharmaceutical materials, an...
In the context of pharmaceutical development, it is abundantly clear that there is a need for greate...
peer-reviewedThe influence of temperature and solvent on the solid-liquid phase diagram of the 1:1 s...
Co-Crystals are crystalline materials formed by bonding between a drug and co-former. This alternati...
Doctor of PhilosophyDepartment of ChemistryChrister B. AakeroyThe impact of the molecular electrosta...
The research presented herein focus upon crystal engineering of co-crystals with an emphasis upon th...
Doctor of PhilosophyDepartment of ChemistryChrister B. AakeröyFour different methods; molecular elec...